SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (508)4/25/1999 10:31:00 AM
From: out_of_the_loop  Read Replies (1) | Respond to of 5582
 
Dan:

Nice post. In a nutshell, you have described the great investing points in GUMM as they relate to Zicam. Some people center on the gum products and look at Zicam as a bonus. Others of us look at Zicam as a sure winner and view the other products, especially the worldwide nicotine cessation gum, as potential winners and Zicam as a bonus. Certainly the marketing of Zicam will open doors for other GUMM products. I am hanging on to this and establishing a bigger position on dips.

Howard



To: DanZ who wrote (508)4/26/1999 12:14:00 AM
From: Eric Fader  Read Replies (1) | Respond to of 5582
 
Dan - I agree with you about the PR. KIDE was going nowhere fast until its mass media coverage kicked in, and then it was one major publication or service after another. I got caught with no KIDE for most of its amazing move, and I feel like I may be playing the same dangerous game now with GUMM, trying to squeeze in a few more short-term plays elsewhere before buying back in. -Eric


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News